After the Bell
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
Jim Cramer urges caution on SHOP, FEYE and PAY, but likes PFPT and NVDA.
Jim Cramer says results can look better when you're expecting the worst.
The company announced Thursday that it will pay $200 million for Motus Therapeutics.
Jim Cramer focuses on the AT&T-Time Warner deal, plus B&G Foods.
©1996-2016 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.